Company Filing History:
Years Active: 2022
Title: Innovations in Somnipathy Treatment by Jong Hoon Jung
Introduction
Jong Hoon Jung is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of sleep disorders. His innovative work focuses on developing compositions that effectively address somnipathy.
Latest Patents
Jong Hoon Jung holds 1 patent related to his research. The patent is titled "Compositions for ameliorating, preventing or treating somnipathy including phloroglucinol as active ingredient and compositions for suppressing intolerance to or alleviating side effects of agonist at benzodiazepine binding site of GABA-A receptor including phloroglucinol as active ingredient." This invention pertains to a pharmaceutical composition and a health functional food composition that utilize phloroglucinol as an active ingredient. The compositions are designed to prevent, treat, or ameliorate somnipathy while also suppressing intolerance and alleviating side effects associated with conventional agonists at the benzodiazepine binding site of the GABA-A receptor.
Career Highlights
Jong Hoon Jung is affiliated with the Korea Food Research Institute, where he conducts his research and development activities. His work is characterized by a focus on creating effective solutions for sleep-related issues, ensuring that his compositions do not impair daytime functioning or cognitive performance.
Collaborations
Jong Hoon Jung collaborates with esteemed colleagues such as Sueng Mok Cho and Min Young Um. Their combined expertise contributes to the advancement of research in the field of somnipathy and related health issues.
Conclusion
Jong Hoon Jung's innovative contributions to the treatment of somnipathy highlight the importance of research in developing effective pharmaceutical solutions. His work not only addresses the symptoms of sleep disorders but also aims to improve the overall quality of life for individuals affected by these conditions.